CORNERSTONE GOVERNMENT AFFAIRS, INC.

Lobbying for NERVGEN PHARMA CORP. · Medical, pharma

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $50,000.00 income · posted Jul 10, 2026

Lobbying activity 3

Veterans

Legislation related to spinal cord injury research and treatment.

Defense

Legislation related to central nervous system research and therapeutics.

Health Issues

Legislation related to spinal cord injury research, therapeutics and approvals.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.